Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease
β Scribed by Markowitz, James; Evans, Jonathan; Pfefferkorn, Marian D.; Griffiths, Anne M.; Keljo, David J.; Mack, David R.; Carvalho, Ryan; Leleiko, Neal S.; Otley, Anthony R.; Rosh, Joel R.; Stephens, Michael C.; Saeed, Shehzad A.; Ashai-Khan, Farhat N.; Bousvaros, Athos; Kay, Marsha H.; Oliva-Hemker, Maria; Grossman, Andrew B.; Sudel, Boris; Kappelman, Michael; Dimmitt, Reed A.; Langton, Christine R.; Hyams, Jeffrey S.
- Book ID
- 122159187
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 60 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i